Key stats
About KOACT US CNS THERAPEUTICS ACTIVE
Expense ratio
0.50%
Home page
Inception date
Sep 3, 2024
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.
Classification
What's in the fund
Exposure type
Health Technology
Cash
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.